The PE Ratio as of May 2025 (TTM) for Propanc Biopharma, Inc. (PPCB) is -0.02

According to Propanc Biopharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -73.63% compared to the average of -0.08 of the last 4 quarters.

Propanc Biopharma, Inc. (PPCB) Historical PE Ratio (quarterly & annually)

How has PPCB PE Ratio performed in the past?

The mean historical PE Ratio of Propanc Biopharma, Inc. over the last ten years is -11294282216.91. The current -0.02 PE Ratio has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), PPCB's PE Ratio was at its highest in in the June 2020 quarter at 0.42. The PE Ratio was at its lowest in in the September 2016 quarter at -48045357104.59.

Propanc Biopharma, Inc. (PPCB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Propanc Biopharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Propanc Biopharma, Inc. (PPCB) Average PE Ratio

How has PPCB PE Ratio performed in the past?

The current PE Ratio of Propanc Biopharma, Inc. (PPCB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Propanc Biopharma, Inc. (PPCB) PE Ratio vs. Peers

How is PPCB’s PE Ratio compared to its peers?

Propanc Biopharma, Inc.’s PE Ratio is greater than Ocean Biomedical, Inc. (-0.09), greater than Enveric Biosciences, Inc. (-0.09), less than Hepion Pharmaceuticals, Inc. (-0.00), greater than Elevation Oncology, Inc. (-0.48), less than AVROBIO, Inc. (2.07), greater than CohBar, Inc. (-0.10), greater than Zura Bio Limited (-1.70), less than CureVac N.V. (4.50), greater than Reata Pharmaceuticals, Inc. (-20.07), less than Krystal Biotech, Inc. (32.41), greater than Vir Biotechnology, Inc. (-1.39),

Build a custom stock screener for Propanc Biopharma, Inc. (PPCB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Propanc Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Propanc Biopharma, Inc. (PPCB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Propanc Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.